Drug Coated PTA Balloon Catheter

OVERVIEW

Drug Coated PTA Balloon Catheter

ENSURE EFFECTIVE DRUG DELIVERY OF A SAFE THERAPEUTIC DOSAGE

The Drug-Coated PTA Balloon Catheter, a versatile and effective PAD treatment option, features unique Coating Technology and is available on the 0.014”, 0.018” and 0.035” balloon catheter platforms.

PTA Drug Coated Balloon Catheter Features

Drug Coated PTA Balloons Catheter

A carrrier or an excipient is not always necessary

Coating Technology

01

The DCB drug dose of paclitaxel is 3μg/mm².

02

UltraFree™ Coating Technology effectively controls paclitaxel crystallization process, resulting in a uniform and stable microcrystal drug coating.

02

03

Particle size distribution test results show that 75% of the particles related are in 5-10μm range.

03

04

The integrated UltraFree™ coating prevents the early drug flaking during the procedure preparation and the device tracking.

04

05

UltraFree™ Coating quickly disintegrates into microcrystalline particles at the lesion site and allows rapid drug transfer to the arterial wall.

06

The effective drug tissue concentration at the lesion site lasts for more than 90 days.

06

More options with the clinically proven platforms

The DCB is based upon the PTA balloon platform and features

Low entry profile and excellent crossability

Advanced pushability

Long balloon lengths up to 220mm

For more information about pta coating, please feel free to contact us!

Zylox tonbridge are a leading player in the peripheral and neurovascular interventional medical device market in China.